Renovaro Bio-AI platform dashboard showing cancer detection and personalized treatment recommendationsRenovaro Bio-AI platform dashboard showing cancer detection and personalized treatment recommendations
About
Team
Approach
Resources
News
Contact
Investor Relations
Track all markets on TradingView
Menu 1
Renovaro Bio-AI platform interface displaying cancer detection and therapeutic development toolsRenovaro Bio-AI platform interface displaying cancer detection & therapeutic development tools

Stay informed with our latest news and stories

May 2025 highlights: merging innovation with action

May was a month of momentum as Renovaro settled into its post-merger identity with BioSymetrics. Here’s what we accomplished.

All articles

Reflections from BIO 2025: A Tale of Two Therapeutic Areas

We at Renovaro recently returned from BIO 2025 in Boston, where the energy was high, the conversations rich, and the insights invaluable. As we showcased our Neurology and Oncology programs, it became clear just how much the industry has shifted over the past year. The convention floor offered a real-time pulse on where the momentum lies – and where strategic opportunities are emerging.

Victoria Catterson invited as Data Community Innovator for the Michael J. Fox Foundation

Contact Us
info@biosymetrics.com
2080 Century Park East, Suite 906, Los Angeles, CA 90067
Privacy protection representing Renovaro's commitment to data security and user privacy
© 2025 Renovaro Biosciences.  All rights reserved.
Designed by Oslop studio
Privacy Policy
Terms of Service
Cookie Settings
Privacy Policy
Terms of Service
Cookie Settings
Designed by Oslop studio